Novo Nordisk Sees First-Half U.S. Launch of Tresiba

Jan. 31 (Bloomberg) -- Jesper Brandgaard, chief financial officer of Novo Nordisk A/S, discusses the company's fourth-quarter profit reported today, growth expectations for the insulin market and the outlook for U.S. approval of its Tresiba diabetes treatment. He speaks from Copenhagen with Francine Lacqua on Bloomberg Television's "The Pulse." (Source: Bloomberg)
The Benefits of EMV Credit Card Chip Technology
19:22 - Ellen Richey, Visa's chief enterprise risk officer, explains the benefits of EMV credit card chip technology. She speaks with Bloomberg's Emily Chang on "Bloomberg West." (Source: Bloomberg)
  • ‘The Martian’: $108 Million Movie Debuts This Weekend
  • What’s Behind the Labor Market is Slow Down?
  • How GE Is Appealing to the Tech Audience